A detailed history of Calamos Wealth Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Calamos Wealth Management LLC holds 31,155 shares of NVO stock, worth $2.72 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
31,155
Previous 49,867 37.52%
Holding current value
$2.72 Million
Previous $7.12 Million 47.89%
% of portfolio
0.2%
Previous 0.39%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $2.23 Million - $2.72 Million
-18,712 Reduced 37.52%
31,155 $3.71 Million
Q2 2024

Jul 25, 2024

BUY
$122.71 - $146.91 $413,287 - $494,792
3,368 Added 7.24%
49,867 $7.12 Million
Q1 2024

May 08, 2024

BUY
$102.11 - $135.92 $94,553 - $125,861
926 Added 2.03%
46,499 $5.97 Million
Q4 2023

Jan 31, 2024

BUY
$87.78 - $105.45 $107,267 - $128,859
1,222 Added 2.76%
45,573 $4.71 Million
Q3 2023

Oct 25, 2023

BUY
$90.94 - $199.54 $2.07 Million - $4.55 Million
22,797 Added 105.77%
44,351 $4.03 Million
Q2 2023

Jul 28, 2023

SELL
$155.98 - $172.65 $55,684 - $61,636
-357 Reduced 1.63%
21,554 $3.49 Million
Q1 2023

May 03, 2023

SELL
$132.34 - $159.14 $669,640 - $805,248
-5,060 Reduced 18.76%
21,911 $3.49 Million
Q4 2022

Jan 25, 2023

SELL
$102.55 - $135.33 $85,424 - $112,729
-833 Reduced 3.0%
26,971 $0
Q3 2022

Oct 24, 2022

SELL
$95.28 - $116.93 $259,638 - $318,634
-2,725 Reduced 8.93%
27,804 $2.77 Million
Q2 2022

Aug 01, 2022

BUY
$103.24 - $121.81 $456,630 - $538,765
4,423 Added 16.94%
30,529 $3.4 Million
Q1 2022

May 03, 2022

BUY
$93.1 - $112.54 $114,513 - $138,424
1,230 Added 4.94%
26,106 $2.9 Million
Q4 2021

Feb 01, 2022

BUY
$95.88 - $117.08 $179,583 - $219,290
1,873 Added 8.14%
24,876 $2.79 Million
Q3 2021

Oct 26, 2021

BUY
$84.42 - $106.62 $36,975 - $46,699
438 Added 1.94%
23,003 $2.21 Million
Q2 2021

Jul 22, 2021

BUY
$67.66 - $84.76 $308,664 - $386,675
4,562 Added 25.34%
22,565 $1.89 Million
Q1 2021

Apr 12, 2021

BUY
$67.06 - $75.82 $129,090 - $145,953
1,925 Added 11.97%
18,003 $1.21 Million
Q4 2020

Jan 27, 2021

SELL
$63.89 - $73.8 $24,725 - $28,560
-387 Reduced 2.35%
16,078 $1.12 Million
Q3 2020

Oct 26, 2020

BUY
$63.69 - $70.22 $195,591 - $215,645
3,071 Added 22.93%
16,465 $1.14 Million
Q2 2020

Jul 27, 2020

BUY
$58.54 - $67.94 $221,866 - $257,492
3,790 Added 39.46%
13,394 $877,000
Q1 2020

Apr 28, 2020

BUY
$49.46 - $64.78 $475,013 - $622,147
9,604 New
9,604 $578,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Calamos Wealth Management LLC Portfolio

Follow Calamos Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Wealth Management LLC with notifications on news.